Skip to main content
Signal8

Glucotrack, Inc. (GCTK)

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

GlucoTrack, Inc. logo

GlucoTrack, Inc.

OTC:GCTKHealthcare
-10.69%$0.4376
Mkt Cap$518K
Float1.09M
O/S1.18M
VOL107K sh
$ Vol$45K
RVOL0.03×
Inst Own1.6%
SI6.7%
Dilution
GlucoTrack, Inc. logoOTC:GCTK$0.4376-10.69%
Historical Data
DateOpenHighLowCloseVolume
Nov 3, 20260.48700.48700.34160.4100107,410
Nov 2, 20260.76000.76040.49000.4900133,709
Oct 30, 20260.53000.91000.50000.8100554,115
Oct 29, 20262.002.241.071.395,470,215
Oct 28, 20262.002.501.802.0528,294,209
Oct 27, 20261.531.761.291.714,718,190
Oct 26, 20260.84001.760.77701.6134,499,304
Oct 23, 20261.181.240.74580.8064361,415
Oct 22, 20261.221.311.121.2072,569
Oct 21, 20261.321.351.251.2837,127
Oct 20, 20261.351.351.181.3025,463
Oct 19, 20261.481.481.361.3751,395
Oct 16, 20261.681.681.411.4573,006
Oct 15, 20261.761.761.521.6677,586
Oct 14, 20262.202.201.721.77180,701
Oct 13, 20262.322.322.142.2282,157
Oct 12, 20262.182.402.082.32160,488
Oct 9, 20262.242.242.002.06118,295
Oct 8, 20262.242.422.162.22104,294
Oct 7, 20262.242.322.202.3052,614
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
Carter Erin Catherine profile photoCarter Erin CatherineGrant/Award386
Malave Luis profile photoMalave LuisGrant/Award463
Malave Luis profile photoMalave LuisGrant/Award4.1K
Balo Andrew K profile photoBalo Andrew KGrant/Award4.1K
Balo Andrew K profile photoBalo Andrew KGrant/Award1.3K
Carter Erin Catherine profile photoCarter Erin CatherineGrant/Award4.1K
Shareholders
1.6%
Institutional
(16)
0.2%
Insiderⓘ
(8)
0.5%
5%+ Owners
(4)
of which <0.1% rests on schedules older than 24 months (1 holder)
97.7%
Unattributed (incl. retail)ⓘ
Institutional1.6%
Insider0.2%
5%+ Beneficial0.5%
Unattributed (incl. retail)97.7%
Sources: 13F, Form 4, 13D/13GO/S: 1.2M · as of 23 Oct 2026 · SEC filings
Insiders & Institutional Holders
About

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes.

The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Key Metrics
Market Cap$518,170
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership1.61%

based on 1.18M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
CountryUSUS
IPO DateApr 25, 2013
Shares Outstanding1.18M
Float1.09M
SEC Float (non-affiliate)1.16M
52-Week Range
$0.3416$225.00
$0.4376(0th percentile)
Volume
Average Daily Volume3.43M
107.41K today vs 3.43M avg(-97%)

30d Avg

3.43M

60d Avg

2.89M

90d Avg

1.90M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...